Literature DB >> 29712852

Revealing the specificity of regulatory T cells in murine autoimmune diabetes.

Allyson Spence1, Whitney Purtha2, Janice Tam1, Shen Dong2, Youmin Kim1, Chia-Hsin Ju3,4, Teague Sterling5, Maki Nakayama6, William H Robinson3,4, Jeffrey A Bluestone2, Mark S Anderson2, Qizhi Tang7,2.   

Abstract

Regulatory T cells (Tregs) control organ-specific autoimmunity in a tissue antigen-specific manner, yet little is known about their specificity in a natural repertoire. In this study, we used the nonobese diabetic (NOD) mouse model of autoimmune diabetes to investigate the antigen specificity of Tregs present in the inflamed tissue, the islets of Langerhans. Compared with Tregs present in spleen and lymph node, Tregs in the islets showed evidence of antigen stimulation that correlated with higher proliferation and expression of activation markers CD103, ICOS, and TIGIT. T cell receptor (TCR) repertoire profiling demonstrated that islet Treg clonotypes are expanded in the islets, suggesting localized antigen-driven expansion in inflamed islets. To determine their specificity, we captured TCRαβ pairs from islet Tregs using single-cell TCR sequencing and found direct evidence that some of these TCRs were specific for islet-derived antigens including insulin B:9-23 and proinsulin. Consistently, insulin B:9-23 tetramers readily detected insulin-specific Tregs in the islets of NOD mice. Lastly, islet Tregs from prediabetic NOD mice were effective at preventing diabetes in Treg-deficient NOD.CD28-/- recipients. These results provide a glimpse into the specificities of Tregs in a natural repertoire that are crucial for opposing the progression of autoimmune diabetes.

Entities:  

Keywords:  T cell receptor; TCR sequencing; antigen specificity; regulatory T cells; type 1 diabetes

Mesh:

Substances:

Year:  2018        PMID: 29712852      PMCID: PMC5960284          DOI: 10.1073/pnas.1715590115

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  50 in total

1.  Inducing and expanding regulatory T cell populations by foreign antigen.

Authors:  Karsten Kretschmer; Irina Apostolou; Daniel Hawiger; Khashayarsha Khazaie; Michel C Nussenzweig; Harald von Boehmer
Journal:  Nat Immunol       Date:  2005-10-23       Impact factor: 25.606

2.  Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter.

Authors:  Yisong Y Wan; Richard A Flavell
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-28       Impact factor: 11.205

3.  Specificity and detection of insulin-reactive CD4+ T cells in type 1 diabetes in the nonobese diabetic (NOD) mouse.

Authors:  Frances Crawford; Brian Stadinski; Niyun Jin; Aaron Michels; Maki Nakayama; Philip Pratt; Philippa Marrack; George Eisenbarth; John W Kappler
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-26       Impact factor: 11.205

4.  Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice.

Authors:  Maki Nakayama; Norio Abiru; Hiroaki Moriyama; Naru Babaya; Edwin Liu; Dongmei Miao; Liping Yu; Dale R Wegmann; John C Hutton; John F Elliott; George S Eisenbarth
Journal:  Nature       Date:  2005-05-12       Impact factor: 49.962

5.  Continuous T cell receptor signals maintain a functional regulatory T cell pool.

Authors:  J Christoph Vahl; Christoph Drees; Klaus Heger; Sylvia Heink; Julius C Fischer; Jelena Nedjic; Naganari Ohkura; Hiromasa Morikawa; Hendrik Poeck; Sonja Schallenberg; David Rieß; Marco Y Hein; Thorsten Buch; Bojan Polic; Anne Schönle; Robert Zeiser; Annette Schmitt-Gräff; Karsten Kretschmer; Ludger Klein; Thomas Korn; Shimon Sakaguchi; Marc Schmidt-Supprian
Journal:  Immunity       Date:  2014-11-06       Impact factor: 31.745

6.  Aire-dependent thymic development of tumor-associated regulatory T cells.

Authors:  Sven Malchow; Daniel S Leventhal; Saki Nishi; Benjamin I Fischer; Lynn Shen; Gladell P Paner; Ayelet S Amit; Chulho Kang; Jenna E Geddes; James P Allison; Nicholas D Socci; Peter A Savage
Journal:  Science       Date:  2013-03-08       Impact factor: 47.728

7.  Cutting edge: normal regional lymph node enrichment of antigen-specific regulatory T cells with autoimmune disease-suppressive capacity.

Authors:  Karen M Wheeler; Eileen T Samy; Kenneth S K Tung
Journal:  J Immunol       Date:  2009-12-15       Impact factor: 5.422

8.  T cell receptor signal strength in Treg and iNKT cell development demonstrated by a novel fluorescent reporter mouse.

Authors:  Amy E Moran; Keli L Holzapfel; Yan Xing; Nicole R Cunningham; Jonathan S Maltzman; Jennifer Punt; Kristin A Hogquist
Journal:  J Exp Med       Date:  2011-05-23       Impact factor: 14.307

9.  LAT-mediated signaling in CD4+CD25+ regulatory T cell development.

Authors:  Surapong Koonpaew; Shudan Shen; Lawrence Flowers; Weiguo Zhang
Journal:  J Exp Med       Date:  2005-12-27       Impact factor: 14.307

10.  CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes.

Authors:  Kristin V Tarbell; Sayuri Yamazaki; Kara Olson; Priscilla Toy; Ralph M Steinman
Journal:  J Exp Med       Date:  2004-06-07       Impact factor: 14.307

View more
  25 in total

Review 1.  Auto-antigen and Immunomodulatory Agent-Based Approaches for Antigen-Specific Tolerance in NOD Mice.

Authors:  Ethan J Bassin; Jon D Piganelli; Steven R Little
Journal:  Curr Diab Rep       Date:  2021-02-06       Impact factor: 4.810

2.  A temporal thymic selection switch and ligand binding kinetics constrain neonatal Foxp3+ Treg cell development.

Authors:  Brian D Stadinski; Sydney J Blevins; Nicholas A Spidale; Brian R Duke; Priya G Huseby; Lawrence J Stern; Eric S Huseby
Journal:  Nat Immunol       Date:  2019-06-17       Impact factor: 25.606

3.  Hybrid insulin peptides are neo-epitopes for CD4 T cells in autoimmune diabetes.

Authors:  Rocky L Baker; Braxton L Jamison; Kathryn Haskins
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2019-08       Impact factor: 3.243

4.  CD4 T Cells Reactive to Hybrid Insulin Peptides Are Indicators of Disease Activity in the NOD Mouse.

Authors:  Rocky L Baker; Braxton L Jamison; Timothy A Wiles; Robin S Lindsay; Gene Barbour; Brenda Bradley; Thomas Delong; Rachel S Friedman; Maki Nakayama; Kathryn Haskins
Journal:  Diabetes       Date:  2018-07-05       Impact factor: 9.461

Review 5.  Interactions between islets and regulatory immune cells in health and type 1 diabetes.

Authors:  Matthew A Budd; Mahdis Monajemi; Sarah J Colpitts; Sarah Q Crome; C Bruce Verchere; Megan K Levings
Journal:  Diabetologia       Date:  2021-09-22       Impact factor: 10.122

Review 6.  Next-generation regulatory T cell therapy.

Authors:  Leonardo M R Ferreira; Yannick D Muller; Jeffrey A Bluestone; Qizhi Tang
Journal:  Nat Rev Drug Discov       Date:  2019-09-20       Impact factor: 84.694

Review 7.  Targeting Stem Cell-Derived Tissue-Associated Regulatory T Cells for Type 1 Diabetes Immunotherapy.

Authors:  Mohammad Haque; Jugal Kishore Das; Xiaofang Xiong; Jianxun Song
Journal:  Curr Diab Rep       Date:  2019-08-30       Impact factor: 4.810

Review 8.  The relationship between TIGIT+ regulatory T cells and autoimmune disease.

Authors:  Darren J Lee
Journal:  Int Immunopharmacol       Date:  2020-03-12       Impact factor: 4.932

9.  CTLA-4-mediated transendocytosis of costimulatory molecules primarily targets migratory dendritic cells.

Authors:  Vitalijs Ovcinnikovs; Ellen M Ross; Lina Petersone; Natalie M Edner; Frank Heuts; Elisavet Ntavli; Alexandros Kogimtzis; Alan Kennedy; Chun Jing Wang; Clare L Bennett; David M Sansom; Lucy S K Walker
Journal:  Sci Immunol       Date:  2019-05-31

10.  Differences in Maturation Status and Immune Phenotypes of Circulating Helios+ and Helios- Tregs and Their Disrupted Correlations With Monocyte Subsets in Autoantibody-Positive T1D Individuals.

Authors:  Yuyue Zhang; Jie Zhang; Yun Shi; Min Shen; Hui Lv; Shu Chen; Yingjie Feng; Heng Chen; Xinyu Xu; Tao Yang; Kuanfeng Xu
Journal:  Front Immunol       Date:  2021-05-12       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.